Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for prevention of polyps in children with FAP
NCT00585312Phase 3Terminated
- Sponsor
- Viatris
- Start
- Sep 2006
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 14
01
Overview
Phase 3, randomised, double-blind trial in familial adenomatous polyposis (FAP) comparing Celecoxib with Placebo (2 arms). Primary endpoint: Time to Disease Progression at 5 years. Started Sep 2006; status: terminated.
02
Drugs
celecoxib
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT00585312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585312.